Type 2 diabetesDiabetic retinopathy
Conditions
Interventions
Active diagnosis and treatment group:Active diagnosis and treatment intervention
Control group:Traditional outpatient follow-up
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.The age is 18~75 years old (including the critical value, subject to the time when the informed consent form is signed); 2.Sex is not limited; 3.According to the diabetes diagnosis and classification criteria issued by the China Diabetes Prevention and Treatment Guidelines (2024 Edition), the diagnosis was type 2 diabetes; 4.Fully understand the purpose, nature, methods and possible adverse reactions of the experiment, voluntarily enter the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Combined with tumor, pregnancy, severe hepatic and renal insufficiency, acute cardiovascular and cerebrovascular diseases, etc; 2.Can't participate in follow-up regularly; 3.There are communication barriers and mental barriers; 4.Participants in other drug trials at present and in recent three months; 5.Any other circumstances that the researcher thinks may affect the patient's informed consent or compliance with the trial plan, or the patient's participation in the trial may affect the trial results or his own safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive compliance rate (HbA1c<7%, blood pressure<130/80mmHg, LDL-C<2.6mmol/L, BMI<24kg/m^2).;DR early screening rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in fasting weight and body mass index (BMI) from baseline;Medication compliance (minor program records missed doses);HbA1c compliance rate (proportion of subjects with HbA1c<7.0% and HbA1c<6.5%);Patient Satisfaction (Survey);Changes from baseline in dynamic blood glucose assessment indicators (Time in Target Range TIR, Standard Deviation of Blood Glucose SD, Maximum Glycemic Variation MAGE);Changes in systolic and diastolic blood pressures from baseline;Changes in fasting lipid profiles (TC, LDL-C, HDL-C, TG) from baseline; | — |
Countries
China
Contacts
Public ContactQing Miao
Huashan Hospital, Fudan University
Outcome results
None listed